• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500257 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2025-10-01 SinoCelltech Ltd view
CYSB2500259 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2025-10-01 SinoCelltech Ltd view
CYSB2500258 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2025-10-01 SinoCelltech Ltd view
JYSB2500201 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-09-05 Bayer Healthcare LLC view
JYSB2500202 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-09-05 Bayer Healthcare LLC view
JYSB2500200 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-09-05 Bayer Healthcare LLC view
CYSB2500197 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2025-09-02 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2500198 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2025-09-02 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2500195 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原15) Supplementary Application 2025-08-29 Hualan Biological Engineering Inc view
CYSB2500196 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原15) Supplementary Application 2025-08-29 Hualan Biological Engineering Inc view
CXSB2500146 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) Supplementary Application 2025-08-20 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2500152 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2025-07-05 China Resources Boya Bio-pharmaceutical Group Co Ltd view
JYSZ2500014 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500017 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500016 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500015 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSB2500082 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-03-26 Bayer Healthcare LLC view
JYSB2500083 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-03-26 Bayer Healthcare LLC view
JYSB2500081 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-03-26 Bayer Healthcare LLC view
JYSB2500026 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-02-08 Pfizer Europe Ma Eeig;Wyeth Farma SA view